Overview

Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
In this study we have evaluated the effects of three different doses of oral testosterone undecanoate in aging men presenting with a combination of symptoms suggestive of hypogonadism and low blood levels of the male hormone testosterone. Specifically, we have studied the effects on: - symptoms suggestive of low testosterone levels - blood testosterone and other hormone levels - bone mass - muscle mass and fat mass - muscle strength - prostate - lipids, hematocrit
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate